BC Week In Review | Oct 20, 2017
Company News

Vir unveils series of deals, additional funding

On Oct. 18, Vir Biotechnology Inc. (San Francisco, Calif.) revealed a crop of new deals and said it has raised more than $500 million to date. CEO George Scangos told BioCentury the company's current round...
Items per page:
1 - 1 of 1